Microvast Holdings, Inc.
MVST Nasdaq Miscellaneous Electrical Machinery, Equipment & Supplies Financials FY2019βFY2025
What Microvast Holdings, Inc. does
No business description yet.
- Legal name
- Microvast Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 16, 2026
- Accession Β· CIK
- 0001628280-26-018264
0001760689
Revenue and margins
Microvast Holdings, Inc. had $428M of revenue in fiscal 2025, up 12.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $56.1M in fiscal 2025, 13.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Microvast Holdings, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 2.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Microvast Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $481M | $256M | $50.2M | $73.0M | $105M |
| Debt incl. finance leases | $13.3M | $46.4M | $79.2M | $112M | $106M |
| Debt / equity | 0.0x | 0.1x | 0.1x | 0.3x | 0.3x |
| Interest coverage | β35.9x | β48.1x | β40.6x | β12.0x | 1.4x |
| Current ratio | 4.0x | 2.2x | 1.1x | 1.3x | 0.9x |
| Quick ratio | 3.7x | 1.8x | 0.7x | 0.9x | 0.7x |
| Total assets | $995M | $985M | $1.1B | $952M | $1.0B |
| Total liabilities | $309M | $372M | $533M | $564M | $595M |
| Shareholders' equity | $687M | $613M | $564M | $388M | $411M |
| Net debt (β = net cash) | β$468M | β$210M | $29.0M | $38.7M | $1.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 3 / 9 | 4 / 9 | 4 / 9 | 5 / 9 | 5 / 9 |
| Accruals ratio | β3.6% | β5.2% | β23.1% | β10.5% | β3.0% | β19.4% | β10.7% |
| Altman Z'' | β480.61 | β3.59 | 2.46 | β0.03 | β2.08 | β3.17 | β3.13 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $76.4M | $108M | $152M | $204M | $307M | $380M | $428M |
| Provision for credit losses | β | β | β | β | $0.2M | $3.7M | $8.0M |
| Gross profit | β$0.2M | $17.1M | β$42.7M | $9.1M | $57.2M | $120M | $122M |
| Research and development | $26.0M | $16.6M | $34.4M | $43.5M | $45.0M | $41.1M | $34.1M |
| Operating income | β$53.9M | β$29.1M | β$194M | β$160M | β$107M | β$116M | $7.0M |
| Interest expense | $6.4M | $5.7M | $5.4M | $3.3M | $2.6M | $9.7M | $4.9M |
| Pretax income | β$59.5M | β$33.6M | β$206M | β$158M | β$106M | β$195M | β$34.5M |
| Income tax | $0.2M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β$5.3M |
| Net income | $3.4M | β$2.4M | β$206M | β$158M | β$106M | β$195M | β$29.2M |
| Diluted EPS | β$0.07 | β$0.82 | β$1.26 | β$0.52 | β$0.34 | β$0.61 | β$0.09 |
| Diluted shares | 0.01B | 0.10B | 0.19B | 0.30B | 0.31B | 0.32B | 0.32B |
| Cash flow | |||||||
| Cash from operations | $13.4M | $15.6M | β$45.0M | β$53.9M | β$75.3M | $2.8M | $75.9M |
| Capital expenditure | $20.3M | $18.6M | $87.9M | $151M | $187M | $27.7M | $19.8M |
| Free cash flow | β$6.9M | β$3.1M | β$133M | β$205M | β$262M | β$24.9M | $56.1M |
| Stock-based compensation | β | $0.0M | $82.9M | $90.8M | $65.0M | $30.8M | $3.1M |
| Balance sheet | |||||||
| Cash and short-term investments | $280M | $21.5M | $481M | $256M | $50.2M | $73.0M | $105M |
| Total debt | β | $12.2M | $13.3M | $46.4M | $79.2M | $112M | $106M |
| Current assets | $0.4M | $189M | $707M | $545M | $426M | $428M | $449M |
| Current liabilities | $0.3M | $184M | $176M | $252M | $403M | $330M | $488M |
| Inventory | β | $45.0M | $53.4M | $84.3M | $150M | $143M | $89.4M |
| Property and equipment, net | β | $198M | $253M | $335M | $621M | $478M | $508M |
| Intangible assets | β | $2.3M | $1.9M | $1.6M | $3.1M | $2.6M | $2.2M |
| Total assets | $280M | $405M | $995M | $985M | $1.1B | $952M | $1.0B |
| Total liabilities | $0.7M | $389M | $309M | $372M | $533M | $564M | $595M |
| Preferred stock | β | β | β | β | β | $0.0M | $0.0M |
| Shareholders' equity | β$320M | $5.0M | $687M | $613M | $564M | $388M | $411M |
| Margins | |||||||
| Gross margin | β0.3% | 15.9% | β28.1% | 4.4% | 18.7% | 31.5% | 28.6% |
| Operating margin | β70.5% | β27.1% | β127.7% | β78.2% | β34.8% | β30.6% | 1.6% |
| Net margin | 4.4% | β2.3% | β135.9% | β77.4% | β34.7% | β51.5% | β6.8% |
| FCF margin | β9.0% | β2.9% | β87.4% | β100.2% | β85.5% | β6.6% | 13.1% |
| Returns | |||||||
| Return on capital | β | β | β70.0% | β31.4% | β14.2% | β21.5% | 1.3% |
| Return on capital employed | β19.2% | β13.2% | β23.7% | β21.8% | β15.4% | β18.7% | 1.4% |
| Return on equity | β | β | β59.7% | β24.3% | β18.1% | β41.1% | β7.3% |
| Return on assets | 1.2% | β0.7% | β29.5% | β16.0% | β10.2% | β19.1% | β3.0% |
| Return on tangible equity | β | β89.1% | β30.2% | β25.9% | β19.0% | β50.7% | β7.2% |
| Growth | |||||||
| Revenue growth | β | 40.7% | 41.3% | 34.6% | 49.9% | 23.9% | 12.6% |
| Net income growth | β | β171.4% | β | β | β | β | β |
| Share count change | β | 1,142.6% | 87.7% | 63.1% | 2.5% | 2.4% | 2.0% |
| Financial health | |||||||
| Debt / equity | β | 2.4x | 0.0x | 0.1x | 0.1x | 0.3x | 0.3x |
| Interest coverage | β8.5x | β5.1x | β35.9x | β48.1x | β40.6x | β12.0x | 1.4x |
| Current ratio | 1.5x | 1.0x | 4.0x | 2.2x | 1.1x | 1.3x | 0.9x |
| Quick ratio | 1.5x | 0.8x | 3.7x | 1.8x | 0.7x | 0.9x | 0.7x |
| Capital allocation | |||||||
| Capex / revenue | 26.5% | 17.3% | 57.8% | 73.8% | 60.9% | 7.3% | 4.6% |
| Stock comp / revenue | β | 0.0% | 54.5% | 44.4% | 21.2% | 8.1% | 0.7% |
| Quality scores | |||||||
| Piotroski F-score | β | 3.0 | 3.0 | 4.0 | 4.0 | 5.0 | 5.0 |
| Altman Z'' | β480.6 | β3.6 | 2.5 | β0.0 | β2.1 | β3.2 | β3.1 |
| Accruals ratio | β3.6% | β5.2% | β23.1% | β10.5% | β3.0% | β19.4% | β10.7% |
Source: SEC EDGAR XBRL filings (CIK 0001760689). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.